NDC Pharmacologic Class N0000008652 Decreased Glycolysis [PE]
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Product Type |
---|---|---|---|---|---|---|
0002-6145 | Baqsimi | Glucagon | Powder | Nasal | Eli Lilly And Company | Human Prescription Drug |
0597-0053 | Glucagen | Glucagon Hydrochloride | Injection, Powder, For Solution | Intramuscular; Intravenous; Subcutaneous | Boehringer Ingelheim Pharmaceuticals, Inc. | Human Prescription Drug |
63323-596 | Glucagon | Glucagon | Injection, Powder, Lyophilized, For Solution | Intramuscular; Intravenous | Fresenius Kabi Usa, Llc | Human Prescription Drug |
72065-120 | Gvoke Hypopen 0.5 mg Auto-Injector | Glucagon Injection, Solution | Injection, Solution | Subcutaneous | Xeris Pharmaceuticals, Inc. | Human Prescription Drug |
72065-121 | Gvoke Hypopen 1 mg Auto-Injector | Glucagon Injection, Solution | Injection, Solution | Subcutaneous | Xeris Pharmaceuticals, Inc. | Human Prescription Drug |
72065-130 | Gvoke Pfs 0.5 mg Pre-filled Syringe | Glucagon Injection, Solution | Injection, Solution | Subcutaneous | Xeris Pharmaceuticals, Inc. | Human Prescription Drug |
72065-131 | Gvoke Pfs 1 mg Pre-filled Syringe | Glucagon Injection, Solution | Injection, Solution | Subcutaneous | Xeris Pharmaceuticals, Inc. | Human Prescription Drug |
There are 7 NDC products with the pharmacologic class Decreased Glycolysis [PE].